Donald N Payne

Array ( [id] => 1523937 [patent_doc_number] => 06352978 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Pharmaceutical compositions containing tobramycin and xanthan gum' [patent_app_type] => B1 [patent_app_number] => 09/902844 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2583 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352978.pdf [firstpage_image] =>[orig_patent_app_number] => 09902844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 709679 [patent_doc_number] => 07056533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Medicament incorporation matrix' [patent_app_type] => utility [patent_app_number] => 09/901425 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11321 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056533.pdf [firstpage_image] =>[orig_patent_app_number] => 09901425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131468 [patent_doc_number] => 20020077323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Use of delta opioid receptor ligands and serotonin reuptake inhibitors in the treatment of chemical dependencies' [patent_app_type] => new [patent_app_number] => 09/901362 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 707 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077323.pdf [firstpage_image] =>[orig_patent_app_number] => 09901362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774746 [patent_doc_number] => 20030018084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Beta-adrenergic blockade reversal of catabolism after severe burn' [patent_app_type] => new [patent_app_number] => 09/901429 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5850 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018084.pdf [firstpage_image] =>[orig_patent_app_number] => 09901429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5999226 [patent_doc_number] => 20020028185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'UVA (> 360-400) and UVB (300-325) specific sunscreens' [patent_app_type] => new [patent_app_number] => 09/900535 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4005 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028185.pdf [firstpage_image] =>[orig_patent_app_number] => 09900535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225356 [patent_doc_number] => 20020004493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Method for the treatment of apolipoprotein E related diseases' [patent_app_type] => new [patent_app_number] => 09/892308 [patent_app_country] => US [patent_app_date] => 2001-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7815 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004493.pdf [firstpage_image] =>[orig_patent_app_number] => 09892308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599517 [patent_doc_number] => 20020042438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Use of ergothioneine and/or its derivatives as an anti-glycation agent' [patent_app_type] => new [patent_app_number] => 09/888525 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3264 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042438.pdf [firstpage_image] =>[orig_patent_app_number] => 09888525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590679 [patent_doc_number] => 20020041901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Pharmaceutical compositions and methods for managing skin conditions' [patent_app_type] => new [patent_app_number] => 09/878231 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12602 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20020041901.pdf [firstpage_image] =>[orig_patent_app_number] => 09878231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420458 [patent_doc_number] => 06506753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-14 [patent_title] => 'Methods of making and using N-desmethylzopiclone' [patent_app_type] => B2 [patent_app_number] => 09/877103 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11220 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506753.pdf [firstpage_image] =>[orig_patent_app_number] => 09877103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598115 [patent_doc_number] => 20020042377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Rotamase enzyme activity inhibitors' [patent_app_type] => new [patent_app_number] => 09/873298 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18485 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 373 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042377.pdf [firstpage_image] =>[orig_patent_app_number] => 09873298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261907 [patent_doc_number] => 06664292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor' [patent_app_type] => B2 [patent_app_number] => 09/873773 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1548 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664292.pdf [firstpage_image] =>[orig_patent_app_number] => 09873773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032110 [patent_doc_number] => 20020018792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Skin care anti-sebum compositions containing 3,4,4-trichlorocarbanilide' [patent_app_type] => new [patent_app_number] => 09/873002 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4667 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20020018792.pdf [firstpage_image] =>[orig_patent_app_number] => 09873002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015228 [patent_doc_number] => 20010051650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Topical compositions comprising ascomycins' [patent_app_type] => new [patent_app_number] => 09/871367 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5192 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051650.pdf [firstpage_image] =>[orig_patent_app_number] => 09871367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510253 [patent_doc_number] => 07199159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Use of biguanide derivatives for making a medicine having a wound healing effect' [patent_app_type] => utility [patent_app_number] => 10/297003 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2871 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199159.pdf [firstpage_image] =>[orig_patent_app_number] => 10297003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636449 [patent_doc_number] => 06380208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-30 [patent_title] => 'Use of nicergoline for treating spasticity' [patent_app_type] => B2 [patent_app_number] => 09/863787 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1976 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380208.pdf [firstpage_image] =>[orig_patent_app_number] => 09863787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596464 [patent_doc_number] => 06492395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Topical formulation of alkyl-, phenyl-pyridone' [patent_app_type] => B1 [patent_app_number] => 09/787474 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3008 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492395.pdf [firstpage_image] =>[orig_patent_app_number] => 09787474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720280 [patent_doc_number] => 20030053968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Compositions for the treatment of pigmentation disorders and methods for their manufacture' [patent_app_type] => new [patent_app_number] => 09/864083 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4285 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20030053968.pdf [firstpage_image] =>[orig_patent_app_number] => 09864083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565499 [patent_doc_number] => 06339095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-01-15 [patent_title] => 'Therapeutic use of 1, 6-dimethyl-8-hydroxymethyl-10--methoxyergoline' [patent_app_type] => B2 [patent_app_number] => 09/863610 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2168 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339095.pdf [firstpage_image] =>[orig_patent_app_number] => 09863610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640761 [patent_doc_number] => 20030212133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Gabapentin analogues for sleep disorders' [patent_app_type] => new [patent_app_number] => 10/297827 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5178 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212133.pdf [firstpage_image] =>[orig_patent_app_number] => 10297827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956311 [patent_doc_number] => 06956062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Storage-stable compositions of glycerol monoalkyl ethers' [patent_app_type] => utility [patent_app_number] => 10/297795 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6008 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/956/06956062.pdf [firstpage_image] =>[orig_patent_app_number] => 10297795 [rel_patent_id] =>[rel_patent_doc_number] =>)